Valion Bio VBIO
NASDAQ VBIO
$0.54 +0.02 (+3.85%)
At close: Nov 13, 2026 · 4:00 PM EST

Valion Bio (VBIO) Long-Term Debt Issuances (2021 - 2023)

Updated

Valion Bio (VBIO) posted Long-Term Debt Issuances of -$100,000 for Q4 2021.

Analysis

Valion Bio (VBIO) Long-Term Debt Issuances (2021 - 2023) Analysis & Trends

For FY2021, Valion Bio's Long-Term Debt Issuances came in at $2.51 million.

  • According to Business Quant data, Long-Term Debt Issuances for the three prior quarters was $450,000 (Q3 2021), $1.75 million (Q2 2021) and $300,000 (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 9.98 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Valion Bio 73,008.00 -25.39 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 584,000.00
Sep 30, 2021 450,000.00
Jun 30, 2021 1.75 Mn
Mar 31, 2021 300,000.00
API Access

Valion Bio Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=VBIO&period=max&api_key=YOUR_API_KEY